Antithrombin III Deficiency
Links shared publicly online about this topic
Antithrombin Deficiency: eMedicine Hematology
emedicine.medscape.com — “Overview: Antithrombin III (ATIII) is currently referred to as antithrombin (AT). Antithrombin (AT) is a 58-kDa molecule belonging to the serine protease inhibitor (serpin) superfamily that plays a central role as an anticoagulant in mammalian circulation systems; ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:50 pm By:
Antithrombin III (ATIII) is currently referred to as antithrombin (AT). Learn about antithrombin deficiency. http://bit.ly/bSjhVt
Octapharma initiates Phase III studies for new, high purity IVIG in treatment of primary immune deficiency
news-medical.net — “Octapharma AG today announced the start of the first of a series of Phase III studies for its new 10% high purity intravenous immunoglobulin (IVIG). The study will investigate the efficacy and safety of this novel immunoglobulin in the treatment of primary immune deficiency and, together with results from additional upcoming studies, will support its regulatory filing in Europe and the US.” View full resource at news-medical.net
Most Recently Shared on February 16, 2010 at 8:50 am By:
Octapharma initiates Phase III studies for new, high purity IVIG in treatment of primary immune deficiency: Octaph... http://bit.ly/a1L0sJ
Glycogen Storage Disease, Type III: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) results from the absence of enzymes that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the defect has systemic consequences, but, in ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:02 pm By:
Type III glycogen storage disease is also called Forbes-Cori disease, & is a result of debranching enzyme deficiecy. http://bit.ly/aGgc9e
Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID
news-medical.net — “Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.” View full resource at news-medical.net
Most Recently Shared on October 6, 2010 at 1:03 pm By:
Interim data from HyQ Phase III clinical study in primary immune deficiency presented at 26th ESID: Data from inte... http://bit.ly/b43kcS
Vitamin B-12 Deficiency & Swollen Hands | LIVESTRONG.COM
livestrong.com — “Vitamin B-12 Deficiency & Swollen Hands. Vitamin B-12 is a vitamin found in many foods as well as in supplement form. A deficiency in this vitamin might occur if your dietary intake is too low, because this vitamin is not...” View full resource at livestrong.com
Most Recently Shared on August 23, 2011 at 9:59 am By:
Vitamin B-12 Deficiency & Swollen Hands: Vitamin B-12 is a vitamin found in many foods as well as in ... http://t.co/IiiWnFB #nutrition
GTx reports positive results from toremifene Phase III clinical trial
news-medical.net — “GTx, Inc. announced today that in the Phase III clinical trial evaluating toremifene 80 mg for the reduction of fractures and treatment of other estrogen deficiency side effects in men with prostate cancer on androgen deprivation therapy (ADT), toremifene treatment demonstrated an improved benefit/risk ratio in men less than 80 years of age. The data were presented yesterday at the 2010 Annual Meeting of the American Society of Clinical Oncology in Chicago.” View full resource at news-medical.net
Most Recently Shared on June 8, 2010 at 6:29 pm By:
Prostate Cancer: GTx reports positive results from toremifene Phase III clinical trial: GTx, Inc. announced today ... http://bit.ly/aY94OK
Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate
news-medical.net — “Rockwell Medical, a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron-deficiency anemia, announced today the design of its Phase III development program for Soluble Ferric Pyrophosphate (SFP) as a continuous iron replacement therapeutic.” View full resource at news-medical.net
Most Recently Shared on October 20, 2010 at 12:29 pm By:
Rockwell Medical announces design of Phase III development program for Soluble Ferric Pyrophosphate: Rockwell Medi... http://bit.ly/dzvyAR
New Vegetarian Enzyme Supplement May Help Improve Your Health, According to Dr. Edward Group III - Yahoo! News
news.yahoo.com — “Read 'New Vegetarian Enzyme Supplement May Help Improve Your Health, According to Dr. Edward Group III' on Yahoo! News. Dr. Edward Group III is excited to announce an all new vegetarian enzyme supplement that is formulated to help improve your health. Many digestive problems, including gas, indigestion, acid reflux and constipation, can be traced back to enzyme deficiencies, according to Dr. Group.Houston, TX (PRWEB) July 26, 2011 Every year the American public spends billions of dollars on food” View full resource at news.yahoo.com
Most Recently Shared on July 26, 2011 at 3:09 pm By:
New Vegetarian Enzyme Supplement May Help Improve Your Health, According to Dr. Edward Group III: Dr. Edward Gr... http://yhoo.it/pVul0i
Show #86, May 2009
accessdata.fda.gov — “Show #86, May 2009” View full resource at accessdata.fda.gov
Most Recently Shared on May 5, 2009 at 12:17 pm By:
FDA: Antiemetic (etc) metoclopramide needs warning abt tardive-dyskinesia risk if used for long time or at high doses http://bitly.com/BAvVA
Ob/Gyn Medical News about Pregnancy
mdlinx.com — “Pregnancy-induced antithrombin deficiency” View full resource at mdlinx.com
Most Recently Shared on May 14, 2010 at 1:42 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pregnancy-induced antithrombin deficiency: Journal of Perinatal Medicine http://bit.ly/dfzSjt #OBG
Congenital Erythropoietic Porphyria: eMedicine Dermatology
emedicine.medscape.com — “Overview: Erythropoietic porphyria (EP) is a rare inborn error of porphyrin-heme synthesis inherited that is as an autosomal recessive trait. The inheritance of 2 mutant alleles for the gene encoding the enzyme uroporphyrinogen III synthase leads to ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 21, 2010 at 12:06 am By:
Congenital erythropoietic protoporphyria is a genetic disorder involving a deficiency of the enzyme ferrochelatase. http://bit.ly/91GRwn
Scurvy: eMedicine Endocrinology
emedicine.medscape.com — “Overview: Scurvy was first described in 1541 by a Dutch physician named Echthius working in Cologne, Germany. Mistakenly, he thought it was an infectious disease. In 1540, a French explorer named Jacques Cartier learned of a remedy ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:31 pm By:
A study by NHANES III has determined 14% of males & 10% of females were vitamin C deficient. More on scurvy. http://bit.ly/bE5yd9
Angioedema, Hereditary: eMedicine Dermatology
emedicine.medscape.com — “Overview: Hereditary angioedema (HAE) is an autosomal dominant disorder of C1 inhibitor (C1-INH) deficiency manifested by painless, nonpruritic, nonpitting swelling of the skin. Type I HAE is defined by low plasma levels of a normal C1-INH protein. ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 17, 2010 at 8:29 pm By:
Susan Scroggins Active Health Library and Health Advocate
Hereditary angioedema occurs in 1 in 10-50,000 people in the U.S. Learn more about this condition and its severity. http://bit.ly/bq2eNv
Results Published In Journal Of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption
medicalnewstoday.com — “Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on October 10, 2009 at 1:01 pm By:
MNT Clinical Trials Health News
Results Published In Journal Of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improv.. http://bit.ly/aOdtA
Trial Approved For Type 1 Diabetes Treatment By Ben-Gurion U. And U. Colorado
medicalnewstoday.com — “The U.S. Food & Drug Administration (FDA) has granted Investigational New Drug (IND) regulatory clearance to initiate a Phase I/II clinical trial evaluating Alpha-1 Antitrypsin (AAT) in type 1 di” View full resource at medicalnewstoday.com
Most Recently Shared on June 30, 2010 at 6:54 pm By:
Trial Approved For Type 1 Diabetes Treatment By Ben-Gurion U. And U. Colorado: The U.S. Food & Drug Administration... http://mnt.to/f/3Fz4
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
-
News-Medical.Net
Medical News from Around the World
-
Susan S
Mom working in health content publishing field. Enjoy sharing information for healthy living.
Advertisement
